查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425013

血液肿瘤检测市场，按产品、技术、最终用户、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Hemato Oncology Testing Market, By Product, By Technology, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 287 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年血液肿瘤检测市场规模为 29.1 亿美元，2023 年至 2030 年CAGR为 11.9%。

血液肿瘤检测市场-市场动态

血液相关癌症盛行率上升及其诊断推动市场需求

在预测期内，研发（R＆D）资金的增加、血癌、骨髓瘤和淋巴瘤的患病率以及高科技产品的可用性预计将推动市场扩张。根据美国癌症协会的数据，非何杰金氏淋巴瘤 (NHL) 是美国最常见的癌症之一，约占美国所有癌症的 4%。到 2023 年，预计将有 80,550 人（其中男性 44,880 名，女性 35,670 名）被诊断为 NHL。

个人化医疗治疗计划的成长是基于整体收集的资料，它有可能彻底改变诊断和医疗保健的提供。由于定序成本不断上升以及基因组学领域人类基因组计划的发展，测序技术，尤其是下一代测序（NGS）的普及，可能会推动血液肿瘤检测市场的扩张。提高 RT-PCR 分析检测急性淋巴细胞白血病 (ALL)、AML 和 CML 等疾病的可及性对于分子诊断检测服务的采用和市场的扩展至关重要。预计药物诊断模型联合开发的增加将进一步推动市场扩张。

血液肿瘤检测市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 11.9% 左右的CAGR成长

根据产品细分，由于治疗疗法和服务，预计服务细分市场将在 2022 年显示最大的市场份额。

从技术细分来看，PCR 细分市场因其高精度和可负担性而成为 2022 年的领先细分市场。

根据最终用户细分，医院细分市场是 2022 年的领先细分市场，主要是由于诊断测试的需求不断增加。

从地区来看，由于白血病、淋巴瘤等，北美是 2022 年主要的收入来源。

血液肿瘤检测市场-細項分析：

全球血液肿瘤检测市场根据产品、技术、最终用户和地区进行细分。

市场依产品分为两类：试剂盒和试剂以及服务。服务领域在市场上占据主导地位。对诊断测试服务不断增长的需求预计将推动仪器需求。

根据技术，市场分为五类：PCR、NGS、IHC、细胞遗传学等。 PCR 领域在市场上占据主导地位，并可能在预测期内保持其主导地位。 PCR 检测对血癌细胞有效，可促进肿瘤细胞生长。

根据最终用户，市场分为三类：医院、学术研究和其他。医院领域在市场中占据主导地位，并可能在预测期内保持其主导地位。先进的医疗设施和实验室环境正在推动市场成长。

血液肿瘤检测市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内主导市场。白血病、淋巴瘤和多发性骨髓瘤发生率的增加是这种激增的原因。此外，尖端技术的出现、先进的医疗保健和医疗基础设施的可用性也有助于该地区的市场扩张。

血液肿瘤检测市场-竞争格局：

血液肿瘤检测市场本质上竞争激烈。此外，为了保持竞争力，市场参与者与实验室合作。例如，Adaptive Biotechnologies 与 GSK 合作，使用其 clonoSEQ 检测来评估 GlaxoSmithKline plc 血液学产品系列中的 MRD。

最近的发展：

2023 年 1 月，安捷伦科技公司与 Akoya Biosciences Inc. 合作开发免疫组织化学诊断解决方案。

目录

第 1 章：血液肿瘤检测市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 血液肿瘤学测试市场片段（按产品）
    • 血液肿瘤检测市场技术片段
    • 最终用户的血液肿瘤测试市场片段
    • 按国家/地区分類的血液肿瘤检测市场片段
    • 按地区分類的血液肿瘤检测市场片段
  • 竞争洞察

第 3 章：血液肿瘤学检验主要市场趋势

  • 血液肿瘤检测市场驱动因素
    • 市场驱动因素的影响分析
  • 血液肿瘤检测市场限制
    • 市场限制影响分析
  • 血液肿瘤检测市场机会
  • 血液肿瘤检测市场未来趋势

第 4 章：血液肿瘤学检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：血液肿瘤检测市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：血液肿瘤检测市场格局

  • 2022 年血液肿瘤检测市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：血液肿瘤检测市场 - 按产品

  • 概述
    • 按产品分類的细分市场占有率分析
    • 试剂盒和试剂
    • 服务

第 8 章：血液肿瘤检测市场 - 依技术

  • 概述
    • 按技术分類的细分市场份额分析
    • 聚合酶炼式反应
    • NGS
    • 免疫组化
    • 细胞遗传学
    • 其他的

第 9 章：血液肿瘤检测市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 学术研究
    • 其他的

第 10 章：血液肿瘤检测市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美血液肿瘤检测主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲血液肿瘤检测主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按产品）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区血液肿瘤检测主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按产品）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲血液肿瘤检测主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 血液肿瘤检测中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 血液肿瘤检测产业

  • 竞争仪表板
  • 公司简介
    • F. Hoffmann-La Roche Ltd.
    • Adaptive Biotechnologies
    • Abbott
    • EntroGen, Inc.
    • Qiagen NV
    • Cepheid
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Amoy Diagnostics Co. Ltd.
    • Oncomine
    • ASURAGEN, INC
    • ArcherDX, Inc.
    • MedGenome Labs

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2213

REPORT HIGHLIGHT

Hemato Oncology Testing Market size was valued at USD 2,910 Million in 2022, expanding at a CAGR of 11.9% from 2023 to 2030.

The field of medicine that researches and treats cancer is called oncology. The study, diagnosis, treatment, and prevention of cancer and blood disorders is known as hematology-oncology. Hematological tests are useful in the diagnosis of leukemia, hemophilia, anemia, infections, and blood-clotting issues.

Hemato Oncology Testing Market- Market Dynamics

Rising prevalence of blood-related cancer and its diagnosis to propel market demand

Over the forecast period, rising funding for research and development (R&D), the prevalence of blood cancer, myeloma, and lymphoma, as well as the availability of high-tech products, are expected to propel market expansion. According to the American Cancer Society, Non-Hodgkin Lymphoma (NHL) is one of the most frequent kinds of cancer in the U.S., accounting for around 4% of all cancers in the country. In 2023, an estimated 80,550 people with 44,880 men and 35,670 women were projected to receive an NHL diagnosis.

Growth in treatment planning in personalized medicine is based on data gathered holistically, it holds the potential to revolutionize diagnosis and the delivery of healthcare. The proliferation of sequencing technologies, especially next-generation sequencing (NGS), due to the rising cost of sequencing and the development of the Human Genome Project in the field of genomics is likely to fuel the hemato oncology testing market's expansion. Increasing the accessibility of RT-PCR analysis for the detection of diseases including acute lymphocytic leukemia (ALL), AML, and CML has been essential to the uptake of molecular diagnostic testing services and the expansion of the market. It is anticipated that a rise in the co-development of the drug diagnostics model would further propel market expansion.

Hemato Oncology Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.9% over the forecast period (2023-2030)

Based on Product segmentation, services segment was predicted to show maximum market share in the year 2022, owing to treatment therapies and services.

Based on Technology segmentation, PCR segment was the leading segment in 2022, due to its high accuracy and affordability.

Based on End-User segmentation, hospitals segment was the leading segment in 2022, mainly due to increasing need for diagnostic tests.

On the basis of region, North America was the leading revenue generator in 2022, owing to leukemia, lymphoma, etc.

Hemato Oncology Testing Market- Segmentation Analysis:

The Global Hemato Oncology Testing Market is segmented on the basis of Product, Technology, End-User, and Region.

The market is divided into two categories based on Product: kits & reagents, and services. The services segment dominates the market. The growing demand for services in diagnostic testing is expected to boost the instruments demand.

The market is divided into five categories based on Technology: PCR, NGS, IHC, cytogenetics, and others. The PCR segment dominates the market and is likely to maintain its dominance during the forecast period. The PCR tests are effective in blood cancer cells which is boosting the segment growth.

The market is divided into three categories based on End-User: hospitals, academic research, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. The advanced healthcare facility and laboratory settings are boosting the market growth.

Hemato Oncology Testing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The increased occurrence of leukemia, lymphoma, and multiple myeloma is the reason for this surge. Furthermore, the region's market expansion has been aided by the advent of cutting-edge technology, the availability of sophisticated healthcare and medical infrastructure.

Hemato Oncology Testing Market- Competitive Landscape:

Hemato Oncology Testing Market is significantly competitive in nature. Moreover, to remain competitive, market players collaborate with laboratories. For example, Adaptive Biotechnologies collaborated with GSK to use its clonoSEQ assay to evaluate MRD in GlaxoSmithKline plc's range of hematology products.

Recent Developments:

In January 2023, Agilent Technologies Inc., partnered with Akoya Biosciences Inc., to develop immunohistochemistry diagnostic solutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMATO ONCOLOGY TESTING MARKET KEY PLAYERS

  • F. Hoffmann-La Roche Ltd.
  • Adaptive Biotechnologies
  • Abbott
  • EntroGen, Inc.
  • Qiagen N.V.
  • Cepheid
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • Amoy Diagnostics Co. Ltd.
  • Oncomine
  • ASURAGEN, INC
  • ArcherDX, Inc.
  • MedGenome Labs

GLOBAL HEMATO ONCOLOGY TESTING MARKET, BY PRODUCT

  • Kits & Reagents
  • Services

GLOBAL HEMATO ONCOLOGY TESTING MARKET, BY TECHNOLOGY

  • PCR
  • NGS
  • IHC
  • Cytogenetics
  • Others

GLOBAL HEMATO ONCOLOGY TESTING MARKET, BY END-USER

  • Hospitals
  • Academic Research
  • Others

GLOBAL HEMATO ONCOLOGY TESTING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemato Oncology Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemato Oncology Testing Market Snippet by Product
    • 2.1.2. Hemato Oncology Testing Market Snippet by Technology
    • 2.1.3. Hemato Oncology Testing Market Snippet by End-User
    • 2.1.4. Hemato Oncology Testing Market Snippet by Country
    • 2.1.5. Hemato Oncology Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemato Oncology Testing Key Market Trends

  • 3.1. Hemato Oncology Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemato Oncology Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemato Oncology Testing Market Opportunities
  • 3.4. Hemato Oncology Testing Market Future Trends

4. Hemato Oncology Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemato Oncology Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hemato Oncology Testing Market Landscape

  • 6.1. Hemato Oncology Testing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemato Oncology Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 7.1.2. Kits & Reagents
    • 7.1.3. Services

8. Hemato Oncology Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 8.1.2. PCR
    • 8.1.3. NGS
    • 8.1.4. IHC
    • 8.1.5. Cytogenetics
    • 8.1.6. Others

9. Hemato Oncology Testing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Academic Research
    • 9.1.4. Others

10. Hemato Oncology Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hemato Oncology Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hemato Oncology Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hemato Oncology Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hemato Oncology Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hemato Oncology Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Hemato Oncology Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Adaptive Biotechnologies
    • 11.2.3. Abbott
    • 11.2.4. EntroGen, Inc.
    • 11.2.5. Qiagen N.V.
    • 11.2.6. Cepheid
    • 11.2.7. Thermo Fisher Scientific, Inc.
    • 11.2.8. Bio-Rad Laboratories, Inc.
    • 11.2.9. Illumina, Inc.
    • 11.2.10. Amoy Diagnostics Co. Ltd.
    • 11.2.11. Oncomine
    • 11.2.12. ASURAGEN, INC
    • 11.2.13. ArcherDX, Inc.
    • 11.2.14. MedGenome Labs

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hemato Oncology Testing Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Hemato Oncology Testing Market, by Product 2018-2030 (USD Million)
  • TABLE Hemato Oncology Testing Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Hemato Oncology Testing Market, by Technology 2018-2030 (USD Million)
  • TABLE Hemato Oncology Testing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Hemato Oncology Testing Market, by End-User 2018-2030 (USD Million)
  • TABLE Hemato Oncology Testing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hemato Oncology Testing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Hemato Oncology Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Hemato Oncology Testing Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Hemato Oncology Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Hemato Oncology Testing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Hemato Oncology Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Hemato Oncology Testing Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Hemato Oncology Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Hemato Oncology Testing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemato Oncology Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemato Oncology Testing Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemato Oncology Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Hemato Oncology Testing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Hemato Oncology Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Hemato Oncology Testing Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Hemato Oncology Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Hemato Oncology Testing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemato Oncology Testing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemato Oncology Testing Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemato Oncology Testing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Hemato Oncology Testing Market, by End-User, 2018-2030 (USD Million)